Medical/Pharmaceuticals

Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

* VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitor * Topline Phase 2a data show VIS-101 provides rapid, robust and durable treatment responses in wet AMD * VIS-101 demonstrated mean BVCA improvements of >10 ETDRS let...

2026-03-13 18:05 7535

Alphamab Oncology Announces IND Application for Innovative EGFR/HER3 Dual Payload Bispecific ADC JSKN021 was Officially Accepted by CDE

SUZHOU, China, March 13, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate (ADC) targeting EGFR and HER3, has been officially...

2026-03-13 09:53 6576

Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement

SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials , a leading global clinical research organization (CRO), today announced it has been named a wi...

2026-03-12 21:02 4146

Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China

Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater China SHANGHAI, March 12, 2026 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the H...

2026-03-12 15:52 5144

Building Resilient Rare Disease Support in Malaysia with Pharm-D Health Science's VALENS Specialised Nutrition

KUALA LUMPUR, Malaysia, March 12, 2026 /PRNewswire/ -- As Malaysia commemorates National Rare Disease Day and marks the launch of the National Policy for Rare Diseases, long-term, sustainable care for individuals living with rare, complex genetic conditions is now gaining growing attention and in...

2026-03-12 10:14 6512

Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office

New Tokyo office strengthens local partnerships, regulatory alignment and global integrations in the world's third largest pharmaceutical market BETHESDA, Md., March 12, 2026 /PRNewswire/ -- Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development...

2026-03-12 07:50 4427

Sky Labs Launches their support of the American Heart Association's 'Established Investigator Award for Clinical Hypertension'

SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- Sky Labs announced on 12th that it is supporting the Established Investigator Award for Clinical Hypertension' developed by the American Heart Association (the Association). This support follows a Memorandum of Understanding (MoU) signed with t...

2026-03-12 07:30 6027

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

WUXI, China, March 12, 2026 /PRNewswire/ -- LabConnect, a leading provider of technology-drivencentral laboratory services and...

2026-03-12 00:35 5094

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading br...

2026-03-11 23:40 5993

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc ., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the ...

2026-03-11 21:38 5439

HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together

2026-03-11 20:09 4469

Haier Biomedical Hosts European Partner Summit in Rome and Advances "In Europe, for Europe" Strategy

ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical recently convened its European Partner Summit in Rome under the theme "Advancing Together - Sharing the Future of Biomedical Innovation," which brought together 37 regional partners and industry leaders fro...

2026-03-11 12:29 7649

Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer

SUZHOU, China, March 11, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and Analytical Development Department, Production Department an...

2026-03-11 09:38 5369

Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026

SHANGHAI, March 10, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its financial re...

2026-03-10 18:40 6817

Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity

-    ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses. -    ASC30 SQ depot formulation maintained weight loss for the four months following the third and final mon...

2026-03-10 18:00 8411

K-pop Singer and Actress Kim Sejeong Named Global Brand Ambassador for 'REJURAN' and 'REJURAN COSMETICS'

GANGNEUNG, South Korea, March 10, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO Jihoon Sohn) announced that singer and actress Kim Sejeong has been named the new global brand ambassador for its flagship brands REJURAN® and REJURAN® COSMETICS.

2026-03-10 16:03 7837

Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude

Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows LONDON, March 10, 2026 /PRNewswire/ -- Clarivate Plc

2026-03-10 16:00 6480

Robot anxiety is highest where robots are least visible, new global study from Hexagon finds

* A global split in confidence: UK adults are most anxious (52%) vs South Korea least (29%), while high-exposure markets like China (75% of adults have seen/used robots) are also the most excited about robots' potential (81%) * The biggest concern is security, not jobs: Hacking is the top conc...

2026-03-10 15:00 4794

Codex Genetics Partners with C2N Diagnostics to Introduce the PrecivityAD2™ Blood Test in Hong Kong, Facilitating Access to Innovative Alzheimer's Disease Diagnostics

HONG KONG, March 10, 2026 /PRNewswire/ -- Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a global leader in in advanced brain health diagnostics. The partnership will introduce the Precivit...

2026-03-10 09:33 5918

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

* Webcast and conference call to be held today, Tuesday March 10 at 9:30 a.m. AEDT (Monday March 9 at 6:30 p.m. EDT). Investors can register at the following link:https://s1.c-conf.com/diamondpass/10053620-ju7y6t.html MELBOURNE, Australia...

2026-03-10 06:34 5627
1 ... 37383940414243 ... 382